Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Plasma Level of Glutamic Acid Decarboxylase 65 (Gad65) Increased in Severely Autistic Iranian Children Publisher Pubmed



Somayeh V1, 2 ; Shahram B3 ; Fatemeh S4 ; Amirhossein A4 ; Fahime Z1, 2 ; Fariba K1
Authors

Source: Bratislava Medical Journal Published:2022


Abstract

INTRODUCTION: Autism spectrum disorder (ASD) is a neurodevelopmental disorder. The major etiological mechanism lies in glutamatergic/GABAergic imbalance. The aim of this study was to evaluate the plasma levels of glutamic acid decarboxylase 65 ( GAD65) protein in mildly and severely autistic patients, and also to compare plasma GAD65 concentration in mild and severe autism. METHOD: In total, 62 autistic patients (aged 6–9 years) and 17 age-matched neurotypically healthy controls were included in the study. The diagnosis, as well as the level of autism, was assessed by applying the Gilliam Autism Rating Scale. Plasma GAD65 protein level was determined using an enzyme-linked immunosorbent assay (ELISA) kit for GAD65. RESULTS: Our fi ndings showed no remarkable alteration in plasma GAD65 concentration in patients with mild autism as compared to healthy subjects, while patients with severe autism showed an increased plasma level of GAD65 as compared to healthy controls and mildly autistic patients. CONCLUSION: Our fi ndings suggest the level of plasma GAD65 to be considered a potential diagnostic biomarker for the severity of autism (Fig. 2, Ref. 40). Text in PDF www.elis.sk © 2022. Bratislava Medical Journal. All Rights Reserved.
Other Related Docs
6. Hormonal Disorders in Autism Spectrum Disorders, Hormone Molecular Biology and Clinical Investigation (2025)
15. Dysregulation of Nf-Κb-Associated Lncrnas in Autism Spectrum Disorder, Frontiers in Molecular Neuroscience (2021)
17. Cognitive Functioning in Adults With Autism Spectrum Disorder, Applied Neuropsychology:Adult (2024)